Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FEm1BcNGuVv3CYneU-V13rIx54NE.uncropped.jpg&w=3840&q=75)
Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 12 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.7%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Multiple sclerosis, MedlinePlus related topics: Multiple Sclerosis, FDA Drug and Device Resources' in the webpage content. This change indicates an update in the information related to genetics topics, specifically focusing on Multiple Sclerosis and related FDA resources.SummaryDifference16%
Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.